Inflammatory prognostic markers in clear cell renal cell carcinoma - preoperative C-reactive protein does not improve predictive accuracy

被引:14
作者
Bedke, Jens [1 ]
Chun, Felix K-H [3 ]
Merseburger, Axel [4 ]
Scharpf, Marcus [2 ]
Kasprzyk, Kathrin [1 ]
Schilling, David [1 ]
Sievert, Karl-Dietrich [1 ]
Stenzl, Arnulf [1 ]
Kruck, Stephan [1 ]
机构
[1] Univ Tubingen, Dept Urol, D-72076 Tubingen, Germany
[2] Univ Tubingen, Inst Pathol, D-72076 Tubingen, Germany
[3] Univ Med Ctr Hamburg Eppendorf, Dept Urol, Hamburg, Germany
[4] Hannover Med Sch, Dept Urol & Urooncol, Hannover, Germany
关键词
renal cell cancer; systemic inflammation; biomarkers; CRP; WBC; threshold; predictive accuracy; CANCER-SPECIFIC SURVIVAL; VALIDATION; BIOMARKER; MORTALITY; IMPACT; MODEL;
D O I
10.1111/j.1464-410X.2012.11642.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To re-evaluate the prognostic and predictive significance of the preoperative white blood cell (WBC) count and C-reactive protein (CRP) that independently predicts patient prognosis and to determine optimal threshold values for CRP. PATIENTS AND METHODS From 1996 to 2005, 327 patients with surgery for clear cell renal cell carcinoma were retrospectively evaluated. Cox proportional hazard models were used, adjusted for the effects of tumour stage, size, Fuhrman grade and Karnofsky index, to evaluate the prognostic significance of WBC count and CRP and to identify threshold values. Identified thresholds were correlated with clinicopathological parameters and used to estimate cancer-specific survival. To prove any additional predictive accuracy of the identified threshold it was compared with a clinicopathological base model using the Harrell concordance index (c-index). RESULTS In univariable analyses WBC count was a significant prognostic marker at a concentration of 9.5/mu L (hazard ratio [HR] 1.83) and 11.0/mu L (HR 2.09) and supported CRP values of 0.25 mg/dL (HR 6.47, P < 0.001) and 0.5 mg/dL (HR 7.15, P < 0.001) as potential threshold values. If adjusted by the multivariable models WBC count showed no clear breakpoint, but a CRP value of 0.25 mg/dL (HR 2.80, P = 0.027) proved to be optimal. Reduced cancer-specific survival was proved for CRP 0.25 mg/dL (median 69.9 vs 92.3 months). Median follow-up was 57.5 months with 72 (22%) tumour-related deaths. The final model built by the addition of CRP 0.25 mg/dL did not improve predictive accuracy (c-index 0.877) compared with the clinicopathological base model (c-index 0.881) which included TNM stage, grading and Karnofsky index. CONCLUSIONS Multivariable analyses revealed that an optimal breakpoint of CRP at a value of 0.25 mg/dL was best to stratify patients at risk of cancer-specific mortality, but CRP 0.25 mg/dL added no additional information in the prediction model. Therefore we cannot recommend measuring CRP as the traditional parameters of TNM stage, grading and Karnofsky index are already of high predictive accuracy.
引用
收藏
页码:E771 / E777
页数:7
相关论文
共 39 条
[1]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[2]  
Bedke J, 2012, EUR UROL, V11, pe76
[3]   Immunologic mechanisms in RCC and allogeneic renal transplant rejection [J].
Bedke, Jens ;
Stenzl, Arnulf .
NATURE REVIEWS UROLOGY, 2010, 7 (06) :339-347
[4]   Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences [J].
Bedke, Jens ;
Buse, Stephan ;
Pritsch, Maria ;
Macher-Goeppinger, Stephan ;
Schirmacher, Peter ;
Haferkamp, Axel ;
Hohenfellner, Markus .
BJU INTERNATIONAL, 2009, 103 (10) :1349-1354
[5]   Inflammation and cancer [J].
Coussens, LM ;
Werb, Z .
NATURE, 2002, 420 (6917) :860-867
[6]   PROGNOSTIC-SIGNIFICANCE OF MORPHOLOGIC PARAMETERS IN RENAL-CELL CARCINOMA [J].
FUHRMAN, SA ;
LASKY, LC ;
LIMAS, C .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1982, 6 (07) :655-663
[7]   Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score [J].
Gakis, Georgios ;
Todenhoefer, Tilman ;
Renninger, Markus ;
Schilling, David ;
Sievert, Karl-Dietrich ;
Schwentner, Christian ;
Stenzl, Arnulf .
BJU INTERNATIONAL, 2011, 108 (11) :1800-1805
[8]   EVALUATING THE YIELD OF MEDICAL TESTS [J].
HARRELL, FE ;
CALIFF, RM ;
PRYOR, DB ;
LEE, KL ;
ROSATI, RA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 247 (18) :2543-2546
[9]   Development and External Validation of a New Outcome Prediction Model for Patients With Clear Cell Renal Cell Carcinoma Treated With Nephrectomy Based on Preoperative Serum C-Reactive Protein and TNM Classification: The TNM-C Score [J].
Iimura, Yasumasa ;
Saito, Kazutaka ;
Fujii, Yasuhisa ;
Kumagai, Jiro ;
Kawakami, Satoru ;
Komai, Yoshinobu ;
Yonese, Junji ;
Fukui, Iwao ;
Kihara, Kazunori .
JOURNAL OF UROLOGY, 2009, 181 (03) :1004-1012
[10]   Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein [J].
Jagdev, S. P. K. ;
Gregory, W. ;
Vasudev, N. S. ;
Harnden, P. ;
Sim, S. ;
Thompson, D. ;
Cartledge, J. ;
Selby, P. J. ;
Banks, R. E. .
BRITISH JOURNAL OF CANCER, 2010, 103 (11) :1649-1656